This comprehensive book presents the most current and innovative information on immunotherapy for breast cancer. It begins with an introduction to the immune system’s role in cancer, covering key concepts such as immunoediting and the cancer-immunity cycle. The text then explores the prognostic and predictive significance of immune responses in breast cancer before moving on to established and emerging therapeutic approaches.
Monoclonal antibody treatments are explained in detail, and particular emphasis is placed on the rapidly expanding use of checkpoint inhibitors, which enhance immune activity by lifting inhibitory mechanisms. The book also provides in-depth coverage of novel vaccine strategies and early therapeutic developments involving chimeric antigen receptor (CAR) T-cell therapy. The final chapters look ahead to future directions in breast cancer immunotherapy.
Written by international experts in their respective fields, this book serves as a valuable and timely resource for researchers and clinical practitioners.
Reviews
There are no reviews yet.